AbbVie
ABBV
#28
Rank
S$403.33 B
Marketcap
$228.00
Share price
2.13%
Change (1 day)
-0.29%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : S$172.92 Billion

According to AbbVie's latest financial reports the company's total liabilities are S$172.92 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$179.14 B9.12%
2023-12-31S$164.18 B0.78%
2022-12-31S$162.90 B-8.08%
2021-12-31S$177.22 B-2.55%
2020-12-31S$181.86 B38.66%
2019-12-31S$131.16 B41.61%
2018-12-31S$92.62 B5.42%
2017-12-31S$87.85 B-1.23%
2016-12-31S$88.95 B28.07%
2015-12-31S$69.46 B103.98%
2014-12-31S$34.05 B8.79%
2013-12-31S$31.30 B8.25%
2012-12-31S$28.91 B194.21%
2011-12-31S$9.82 B40.47%
2010-12-31S$6.99 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$163.87 B-5.23%๐Ÿ‡บ๐Ÿ‡ธ USA
S$99.99 B-42.17%๐Ÿ‡บ๐Ÿ‡ธ USA
S$84.55 B-51.10%๐Ÿ‡บ๐Ÿ‡ธ USA
S$112.78 B-34.78%๐Ÿ‡บ๐Ÿ‡ธ USA
S$52.15 B-69.84%๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.86 B-91.40%๐Ÿ‡บ๐Ÿ‡ธ USA
S$76.35 B-55.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$82.87 B-52.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$1.48 B-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA